Figure 2.

Anti-CDX2 nuclear immunostaining: (A) HCT116 cell line (B) circulating tumor cells (CTCs) in a patient with colorectal cancer (Obj. × 40).

Anti-CDX2 nuclear immunostaining: (A) HCT116 cell line (B) circulating tumor cells (CTCs) in a patient with colorectal cancer (Obj. × 40).